K-numberK243062
Device nameBD Intelliport System; BD Intelliport Reader (516230); BD Intelliport Sensor (516229); BD Intelliport Gateway (516232); BD Intelliport Mount (516233); BD Intelliport Charger (516231)
ApplicantBecton Dickinson
Product codePHC
Device classClass II
Decision dateJun 20, 2025
DecisionSubstantially Equivalent
Regulation880.5725
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The BD Intelliport System is an automated medication administration record-keeping system that integrates into intravenous lines to identify, measure, and document medications administered to patients during anesthesia procedures. It captures drug information from RFID-encoded syringes, measures the volume of medication delivered, and wirelessly transmits dose data to the patient's electronic medical record in hospital or surgical settings for patients weighing over 20 kg.

Technological characteristics

The subject device differs from the predicate by using RFID-labeled syringes instead of 2D barcodes, limiting compatible syringe sizes to 1–30 mL rather than 1–60 mL, changing the reader design and charger capacity from 5 to 2 bays, updating the flow algorithm to support refrigerated medications, and adding expired medication alerts. Both devices share the same intended use, fundamental technology, mechanism of action, and sterility levels.

Test standards cited

ISO 10993-1 (biocompatibility), IEC 60601-1 and IEC 60601-2 (electrical safety and electromagnetic compatibility), ISO 80369-7 (IV port compatibility), USP 788 and ISO 8536-4 (particulate testing), and FDA guidance on human factors and usability engineering (2016).

Substantial equivalence argument

The subject device maintains identical intended use and patient population as the predicate, with the same fundamental technology and mechanism for measuring and recording IV bolus injections. Design modifications (RFID reading, syringe size limits, updated algorithm, new alerts) were qualified through comprehensive non-clinical testing and human factors studies that demonstrate the subject device performs safely and effectively without raising different safety or effectiveness questions; testing confirms the expanded capability for refrigerated medications and improved user interface do not compromise device performance within the specified operating parameters.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →